Lates News

Daily Economic News reported on November 5th that Pacific Securities issued a research report giving Vedic Medical (688617.SH) a "buy" rating. The main reasons for the rating include: 1) implementation of fee policies in multiple regions, with an expected PFA surgery volume of over 5000 cases; 2) steady increase in market share in coronary and peripheral areas, with channel inventory at normal levels; 3) stabilizing gross profit margin, with a slight increase in expense ratio in the third quarter.